s6y Raphael Pharmaceutical Inc. EFFECT

Raphael Pharmaceutical Inc. EFFECT, filed Jun 13, 2023: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 13, 2023
Accession Number: 0001213900-23-044791
Submission Type: POS AM
CIK: 0001415397
Company Name: Raphael Pharmaceutical Inc.
File Number: 333-260766